Evidence map›Paper›PMID 32241221›Full record

ArticleVirulence2020

Characterization of Schu S4

Aimee L Cunningham, Barbara J Mann, Aiping Qin, Araceli E Santiago, Christen Grassel, Michael Lipsky, Stefanie N Vogel, Eileen M Barry

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The immune response toFrontiers in microbiology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. The intracellular pathogenLife science alliance · 2022
    Article
  9. Article
  10. Deletion Mutants ofPathogens (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aimee L CunninghamCenter for Drug Evaluation and Research, FDA, Silver Spring, MD, USA.
Barbara J MannDepartment of Medicine, Division of Infectious Diseases and International Heath, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0002-5549-2562
Aiping QinDepartment of Medicine, Division of Infectious Diseases and International Heath, University of Virginia, Charlottesville, VA, USA.
Araceli E SantiagoDepartment of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Christen GrasselCenter for Vaccine Development, University of Maryland Baltimore, Baltimore, MD, USA.
Michael LipskyDepartment of Pathology, University of Maryland Baltimore, Baltimore, MD, USA.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland Baltimore, Baltimore, MD, USA.
Eileen M BarryCenter for Vaccine Development, University of Maryland Baltimore, Baltimore, MD, USA.ORCID 0000-0002-5326-0047
University of Maryland, Baltimore · USUniversity of Virginia · USCenter for Drug Evaluation and Research · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
Correlates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia ModelR01AI123129 · NIAID · ALBANY MEDICAL COLLEGE · PI BARRY, EILEEN M., HAZLETT, KARSTEN R.O. · 2016 to 2020
$3.7M
Advancement of a Defined, Protective, Live Attenuated Tularemia VaccineR01AI102966 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2013 to 2015
$2.1M
Advancement of New Live Attenuated F. Tularensis Type A Vaccine StrainsU01AI077909 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2009 to 2010
$1.1M
NIAID NIH HHS R01 AI102966NIAID NIH HHS R01 AI123129NIAID NIH HHS U01 AI077909NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

There is a need for development of an effective vaccine against

Indexed as

AnimalsAntibodies, BacterialBacterial VaccinesCytokinesDisease Models, AnimalFemaleFrancisella tularensisGene DeletionMacrophagesMiceMice, Inbred C57BLVaccines, AttenuatedVirulenceAntibodies, BacterialBacterial VaccinesCytokinesVaccines, AttenuatedaroDcytokinesdisseminationFrancisella tularensispathologySchu S4tularemiavaccine

Identifiers

PMID32241221
PMCPMC7161688
OpenAlexW3015009338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.